HK1124616A1 - Preparation of a crystalline antibiotic substance - Google Patents
Preparation of a crystalline antibiotic substanceInfo
- Publication number
- HK1124616A1 HK1124616A1 HK09102126.4A HK09102126A HK1124616A1 HK 1124616 A1 HK1124616 A1 HK 1124616A1 HK 09102126 A HK09102126 A HK 09102126A HK 1124616 A1 HK1124616 A1 HK 1124616A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- preparation
- antibiotic substance
- crystalline antibiotic
- crystalline
- substance
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
- C07J13/007—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 17 (20)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
- Cephalosporin Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US73124705P | 2005-10-31 | 2005-10-31 | |
| PCT/DK2006/000600 WO2007051468A2 (en) | 2005-10-31 | 2006-10-30 | Preparation of an antibiotic crystalline fusidic acid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1124616A1 true HK1124616A1 (en) | 2009-07-17 |
Family
ID=37944062
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK09102126.4A HK1124616A1 (en) | 2005-10-31 | 2009-03-05 | Preparation of a crystalline antibiotic substance |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US8933063B2 (xx) |
| EP (1) | EP1945654B1 (xx) |
| JP (1) | JP5405114B2 (xx) |
| KR (2) | KR101463402B1 (xx) |
| CN (1) | CN101351471B (xx) |
| AU (1) | AU2006310873B2 (xx) |
| BR (1) | BRPI0618081A2 (xx) |
| CA (1) | CA2627740C (xx) |
| DK (1) | DK1945654T3 (xx) |
| ES (1) | ES2553165T3 (xx) |
| HK (1) | HK1124616A1 (xx) |
| IL (1) | IL190880A (xx) |
| MY (1) | MY148124A (xx) |
| PL (1) | PL1945654T3 (xx) |
| PT (1) | PT1945654E (xx) |
| RU (1) | RU2418806C2 (xx) |
| WO (1) | WO2007051468A2 (xx) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2470645C2 (ru) * | 2007-09-10 | 2012-12-27 | Гленмарк Фармасьютикалс Лимитед | Фармацевтическая композиция для местного применения, содержащая комбинацию фузидовой кислоты и кортикостероида |
| JP5698979B2 (ja) | 2007-10-25 | 2015-04-08 | センプラ ファーマシューティカルズ，インコーポレイテッド | マクロライド系抗菌剤の調製プロセス |
| JP5602748B2 (ja) | 2008-10-24 | 2014-10-08 | センプラ ファーマシューティカルズ，インコーポレイテッド | トリアゾール含有マクロライドを用いた生体防御 |
| US9937194B1 (en) | 2009-06-12 | 2018-04-10 | Cempra Pharmaceuticals, Inc. | Compounds and methods for treating inflammatory diseases |
| CN101792476B (zh) * | 2010-03-12 | 2015-04-08 | 江苏九阳生物制药有限公司 | 一种提取分离夫西地酸的方法 |
| RU2472490C1 (ru) * | 2011-08-05 | 2013-01-20 | Открытое акционерное общество "Биосинтез" | Средство для лечения кожных гнойных инфекций, составы и способы получения |
| RU2512757C1 (ru) * | 2012-10-16 | 2014-04-10 | Открытое акционерное общество "Биосинтез" | Антибактериальное и регенерирующее средство, выполненное в форме маслянистого геля для наружного применения |
| JP6426696B2 (ja) | 2013-03-14 | 2018-11-21 | センプラ ファーマシューティカルズ，インコーポレイテッド | 呼吸器疾患の治療のための方法および製剤 |
| CN103214540B (zh) * | 2013-04-28 | 2015-11-18 | 华北制药集团新药研究开发有限责任公司 | 一种夫西地酸钠晶体及其制备方法 |
| WO2015192031A1 (en) * | 2014-06-12 | 2015-12-17 | Cem-102 Pharmaceuticals, Inc. | Compositions and methods for treating bone and joint infections |
| CN112986289A (zh) * | 2021-02-02 | 2021-06-18 | 海南海力制药有限公司 | 一种阿莫西林胶囊的一致性评价检测方法 |
| CN114432250B (zh) * | 2022-02-22 | 2022-10-04 | 深圳市泰力生物医药有限公司 | 一种非晶态夫西地酸的稳定方法 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB930786A (en) * | 1960-09-21 | 1963-07-10 | Knud Abildgaard | Improvements in or relating to antibiotics containing a cyclopentanophenanthrene nucleus |
| GB999794A (en) | 1961-08-02 | 1965-07-28 | Knud Abildgaard | Improvements in or relating to the production of an antibiotic containing a cyclopentanophenanthrene nucleus and salts thereof |
| CH458624A (de) | 1960-09-21 | 1968-06-30 | Leo Pharm Prod Ltd | Verfahren zur Herstellung eines neuen Antibiotikums und seiner Salze |
| US3072531A (en) * | 1960-09-21 | 1963-01-08 | Leo Pharm Prod Ltd | Antibiotic and therapeutic compositions thereof |
| AT252446B (de) | 1961-06-23 | 1967-02-27 | Leo Pharm Prod Ltd | Verfahren zur Herstellung der neuen, antibiotisch aktiven Verbindung Fusidinsäure und ihrer Salze |
| FR1326076A (fr) | 1962-06-19 | 1963-05-03 | Rech S Pour Applic Therapeutiq | Nouveau procédé pour préparer l'acide fusidique |
| GB8500310D0 (en) | 1985-01-07 | 1985-02-13 | Leo Pharm Prod Ltd | Pharmaceutical preparation |
| GB9415048D0 (en) | 1994-07-26 | 1994-09-14 | Leo Pharm Prod Ltd | Tablet |
| US6103884A (en) * | 1996-03-27 | 2000-08-15 | The University Of Michigan | Glycosylated analogs of fusidic acid |
| DK1232173T3 (da) * | 1999-10-15 | 2003-09-29 | Leo Pharma As | Nye fusidinsyrederivater |
| RU2192470C2 (ru) * | 2000-09-05 | 2002-11-10 | Открытое акционерное общество "Биосинтез" | Способ получения фузидиевой кислоты |
| ES2204331B1 (es) | 2002-10-09 | 2005-03-01 | Ercros Industrial, S.A. | Procedimiento para la obtencion de acido fusidico a partir de un caldo de fermentacion. |
| ES2208110B1 (es) * | 2002-11-19 | 2005-03-16 | Ercros Industrial, S.A. | Formas cristalinas de acido fusidico y procedimientos para su obtencion. |
| MY140194A (en) * | 2003-07-16 | 2009-11-30 | Leo Pharma As | Novel fusidic acid derivatives |
-
2006
- 2006-10-30 AU AU2006310873A patent/AU2006310873B2/en active Active
- 2006-10-30 PT PT68055409T patent/PT1945654E/pt unknown
- 2006-10-30 KR KR1020087010614A patent/KR101463402B1/ko active IP Right Grant
- 2006-10-30 DK DK06805540.9T patent/DK1945654T3/en active
- 2006-10-30 CN CN2006800495474A patent/CN101351471B/zh active Active
- 2006-10-30 KR KR1020147014220A patent/KR20140079867A/ko not_active Application Discontinuation
- 2006-10-30 EP EP06805540.9A patent/EP1945654B1/en active Active
- 2006-10-30 MY MYPI20081282A patent/MY148124A/en unknown
- 2006-10-30 PL PL06805540T patent/PL1945654T3/pl unknown
- 2006-10-30 WO PCT/DK2006/000600 patent/WO2007051468A2/en active Application Filing
- 2006-10-30 US US12/084,231 patent/US8933063B2/en active Active
- 2006-10-30 CA CA2627740A patent/CA2627740C/en not_active Expired - Fee Related
- 2006-10-30 ES ES06805540.9T patent/ES2553165T3/es active Active
- 2006-10-30 BR BRPI0618081-7A patent/BRPI0618081A2/pt not_active IP Right Cessation
- 2006-10-30 JP JP2008538256A patent/JP5405114B2/ja active Active
- 2006-10-30 RU RU2008121958/04A patent/RU2418806C2/ru active
-
2008
- 2008-04-15 IL IL190880A patent/IL190880A/en active IP Right Grant
-
2009
- 2009-03-05 HK HK09102126.4A patent/HK1124616A1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PT1945654E (pt) | 2015-12-01 |
| CN101351471B (zh) | 2012-10-03 |
| RU2008121958A (ru) | 2009-12-10 |
| CA2627740A1 (en) | 2007-05-10 |
| US8933063B2 (en) | 2015-01-13 |
| EP1945654B1 (en) | 2015-08-19 |
| AU2006310873B2 (en) | 2012-05-24 |
| KR101463402B1 (ko) | 2014-11-26 |
| KR20080063816A (ko) | 2008-07-07 |
| WO2007051468A3 (en) | 2007-10-04 |
| JP5405114B2 (ja) | 2014-02-05 |
| CN101351471A (zh) | 2009-01-21 |
| IL190880A (en) | 2016-11-30 |
| AU2006310873A1 (en) | 2007-05-10 |
| BRPI0618081A2 (pt) | 2012-02-22 |
| RU2418806C2 (ru) | 2011-05-20 |
| DK1945654T3 (en) | 2015-11-30 |
| KR20140079867A (ko) | 2014-06-27 |
| EP1945654A2 (en) | 2008-07-23 |
| US20090131389A1 (en) | 2009-05-21 |
| IL190880A0 (en) | 2008-11-03 |
| ES2553165T3 (es) | 2015-12-04 |
| MY148124A (en) | 2013-02-28 |
| JP2009513683A (ja) | 2009-04-02 |
| PL1945654T3 (pl) | 2016-02-29 |
| CA2627740C (en) | 2012-09-11 |
| WO2007051468A2 (en) | 2007-05-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL190880A0 (en) | Preparation of a crystalline antibiotic substance | |
| ZA200708071B (en) | Crystalline form of a quinolinone-carboxamide compound | |
| GB0504995D0 (en) | Use of a compound | |
| PL2016045T3 (pl) | Krystaliczna postać tygecykliny i sposoby jej otrzymywania | |
| IL196706A0 (en) | Crystalline forms of rapamycin analogs | |
| ZA200903971B (en) | Crystalline modification of fipronil | |
| AP2007004282A0 (en) | Derivatives of A 1-phenyltriazole as antiparasiticagents | |
| ZA200903967B (en) | Crystalline modification of fipronil | |
| IL198262A0 (en) | Crystalline modification of fipronil | |
| IL183380A0 (en) | Crystalline forms of linezolid intermediate | |
| ZA200903972B (en) | Crystalline modification of fipronil | |
| PL1836159T3 (pl) | Pochodne binaftylu, będące antybiotykami | |
| IL187981A0 (en) | Crystalline forms of a pyrrolotriazine compound | |
| EP1858844A4 (en) | NEW CRYSTALLINE FORMS OF ANTIDIABETIC COMPOUNDS | |
| IL195061A0 (en) | Crystalline forms of atorvastatin | |
| GB0506967D0 (en) | Novel crystalline salt | |
| ZA200806859B (en) | Novel crystalline compounds | |
| EP1951257A4 (en) | CRYSTALLINE FORMS | |
| EP1793812A4 (en) | ANTIBIOTIC COMPOUND | |
| IL195092A0 (en) | Crystalline form of (s)-1-phenylethylammonium (r)-diphenyl-methanesulphinyl-acetate | |
| IL186174A0 (en) | A process for the preparation of 6-0-methyl erythromycin a derivative | |
| EP1756034A4 (en) | ANTIBIOTIC COMPOUND | |
| IL187326A0 (en) | Crystalline form of benzazepinium maleate derivative | |
| EP2119792A4 (en) | INNOVATIVE MACROLIDE COMPOUND | |
| GB0613566D0 (en) | Crystalline sodium atorvastatin |